Public Law 113–233: To expand the program of priority review to encourage treatments for tropical diseases.Public Law233Public Law 113–233128 Stat. 21272014-12-162014-12-16United States Government Publishing OfficeNational Archives and Records AdministrationOffice of the Federal Registertext/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.GPO Locator to USLM Converter 4.15.31;Stage2.202507022026-01-03113publicPUBLIC LAW 113–233—DEC. 16, 2014128 STAT. 2127Public Law113–233113th CongressAn ActTo expand the program of priority review to encourage treatments for tropical diseases.
Dec. 16, 2014
[S. 2917]
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
Adding Ebola to the FDA Priority Review Voucher Program Act.
SECTION 1.
21 USC 301 note.
SHORT TITLE. This Act may be cited as the “Adding Ebola to the FDA Priority Review Voucher Program Act”.SEC. 2. PRIORITY REVIEW TO ENCOURAGE TREATMENTS FOR TROPICAL DISEASES. Section 524 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n) is amended—(1) in subsection (a)(3)—(A) by redesignating subparagraph (Q) as subparagraph (R);(B) by inserting after subparagraph (P) the following:“(Q) Filoviruses.”; and(C) in subparagraph (R), as so redesignated, by striking “regulation by” and inserting “order of”; and(2) in subsection (b)—(A) in paragraph (2), by adding “There is no limit on the number of times a priority review voucher may be transferred before such voucher is used.” after the period at the end; and128 STAT. 2128(B) in paragraph (4), by striking “365 days” and inserting “90 days”.ApprovedDecember 16, 2014.LEGISLATIVE HISTORY—S. 2917:CONGRESSIONAL RECORD, Vol. 160 (2014):